Predictors of survival in a group of patients with chronic airflow obstruction

Journal of Clinical Epidemiology

Volumn 51, Issue 7, 1998, Pages 547-555

  Piccioni, P ^a   Caria, E ^a   Bignamini, E ^a   Forconi, G ^a   Nebiolo, F ^a   Arossa, W ^a   Bugiani, M ^a  

^a Dispensario di Igiene Sociale   (Italy)

Author keywords

Adherence; Care program; Chronic airflow obstruction (CAO); Survival

Indexed keywords

OXYGEN;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COR PULMONALE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE PLANNING; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GAS ANALYSIS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; VITAL CAPACITY;

EID: 0032125848     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00022-5     Document Type: Article

References (36)

1. Howard P. Natural history of obstructive airways disease and hypoxia. Implications for therapy Lung. 168(Suppl.):1990;743-750.
2. Snider G.L. Chronic obstructive pulmonary disease. A definition and implications of structural determinants of airflow obstruction for epidemiology Am Rev Respir Dis. 140(Suppl.):1989;S3-S8.
3. Snider G.L. Chronic obstructive pulmonary disease. Risk factors, pathophysiology and pathogenesis Ann Rev Med. 40:1989;411-429.
4. ERS Consensus Statement. Eur Respir J 1995; 8: 1398-1420.
5. Feinleib M., Rosemberg H.M., Collins J.G., Delozier J.E., Pokras R., Chevarley F.M. Trends in COPD morbidity and mortality in the United States. Am Rev Respir Dis. 140(Suppl.):1989;S9-S18.
6. Manfreda J., Mao Y., Litven W. Morbidity and mortality from chronic obstructive pulmonary disease. Am Rev Respir Dis. 140(Suppl.):1989;S19-S26.
7. Lebowitz M.D. The trends in airway obstructive disease morbidity in the Tucson epidemiological study. Am Rev Respir Dis. 140(Suppl.):1989;S35-S41.
8. Hodgkin J.E. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med. 11:1990;555-569.
9. Anthonisen N.R. Prognosis in chronic obstructive diseases. Results from multicenter clinical trials Am Rev Respir Dis. 140(Suppl.):1989;S95-S99.
10. Anthonisen N.R., Wright E.C., Hodgkin J.E., the I.P.P.B., Trial Group Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 133:1986;14-20.
11. Boushy S., Thompson H.K., North L.B., Beale A.R., Snow J.R. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 108:1973;1373-1383.
12. Farebrother M.J.B., Kelson M.C., Heller R.F., on behalf of the E.E.C., Working Party Death certification of farmer's lung and chronic airway diseases in different countries of the EEC. Br J Dis Chest. 79:1985;352-360.
13. Burrows B., Earle R.H. Prediction of survival in patients with chronic airways obstruction. Am Rev Respir Dis. 99:1969;865-871.
14. Traver G.A., Cline M.G., Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. Am Rev Respir Dis. 119:1979;895-902.
15. Spinaci S., Bugiani M., Arossa W., Bucca C., Rolla G. A multivariate analysis of the risk in chronic obstructive lung disease (COLD). J Chron Dis. 38:1985;449-453.
16. Campbell A.H., Barter C.E., O'Connell J.M., Huggins R. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax. 40:1985;741-748.
17. Petty T.L., Pierson D.J., Dick N.P., Hudson L.D., Walker S.H. Follow up evaluation of a prevalence study for chronic bronchitis and chronic airway obstruction. Am Rev Respir Dis. 114:1976;881-890.
18. Fletcher C., Peto R. The natural history of chronic airflow obstruction. Br M J. 1:1977;1645-1648.
19. Tiep B.L. Long term oxygen therapy. Clin Chest Med. 11(3):1990;505-517.
20. Stewart E.G., Howard P. Indications for long-term oxygen therapy. Respiration. 59(Suppl. 2):1992;8-13.
21. Postma D.S., Peters I., Steenhuis E.J., Sluiter H.J. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J. 1:1988;22-26.
22. Dompeling E., van Schayck C.P., Molema J., Folgering H., van Grusven P.M., van Weel C. Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J. 5:1992;945-952.
23. Anthonisen N.R., Wright E.C., IPPB Trial Group Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis. 133:1986;814-819.
24. Kerstjen H.A., Brand P.L.P., Hughes M.D., the Dutch Chronic Non Specific Lung Disease Study Group A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Eng J Med. 327:1992;1413-1419.
25. Thomas P., Pugsley J.A., Stewart J.H. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease. Chest. 101:1992;160-165.
26. Chung K.F. Long-term inhaled corticosteroid therapy in chronic airways obstruction. Eur Respir J. 5:1992;913-914.
27. Hay J.G., Stone P., Carter J., Church S.et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J. 5:1992;659-664.
28. American Thoracic Society Chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis. 85:1992;762.
29. Cara M, Hentz P. Aide-memoire pour la pratique de l'examen de la fonction ventilatoire par la spirographie. Commission des Communites Europeenes - CECA. Collection d'Higiene et de Medicine du Travail 1971; 11.
30. Sayed Nour EL, Suchindran CM. Multistate life tables: Theory and application. In: Pranab K, Ed. Biostatistics: Statistics in Biomedical, Public Health and Environmental Sciences. Amsterdam, 1985: 143-162.
31. State of Health of Turin Population - Mortality 1982. Turin, 1984.
32. Atkin M., Anderson D., Francis B. Statistical Modelling in GLIM. 1989;Oxford Science Publication, Oxford. 6.
33. Cooreman J., Thom T.J., Higgins M.W. Mortality from chronic obstructive pulmonary diseases and asthma in France 1969-1983. Chest. 97(1):1990;213-219.
34. Speizer F.E., Fay M.E., Dockery D.W., Ferris B.J. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis. 140(Suppl.):1989;S49-S55.
35. Mac Nee W. Predictors of survival in patients treated with long-term oxygen therapy. Respiration. 59(Suppl. 2):1992;5-7.
36. Gross N.J. COPD. A disease of reversible airflow obstruction Am Rev Respir Dis. 133:1986;725-726.